Testing effectiveness (Phase 2)Study completedNCT02491892What this trial is testingPertuzumab in Participants With Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 79
Testing effectiveness (Phase 2)Looking for participantsNCT06656624What this trial is testingEfficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)Who this might be right forAdvanced Breast Cancer The First Affiliated Hospital with Nanjing Medical University 190
Testing effectiveness (Phase 2)UnknownNCT05845138What this trial is testingSHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.Who this might be right forBreast Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 116
Not applicableNot Yet RecruitingNCT07389200What this trial is testingApplication of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast CancerWho this might be right forBreast CancerBreast Cancer With Low to Intermediate HER2 Expression Hao Xu 400
Large-scale testing (Phase 3)Study completedNCT01479244What this trial is testingEfficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer RecurrenceWho this might be right forBreast Cancer With Low to Intermediate HER2 Expression Galena Biopharma, Inc. 758
Testing effectiveness (Phase 2)Looking for participantsNCT07497386What this trial is testingA Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast CancerWho this might be right forUnresectable Locally Recurrent Breast CancerUnresectable Locally Metastatic Breast Cancer Jiangsu HengRui Medicine Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT03321981What this trial is testingMCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.Who this might be right forBreast Cancer Metastatic Merus B.V. 105
Testing effectiveness (Phase 2)Looking for participantsNCT06439771What this trial is testingEvaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BCWho this might be right forLocally Advanced or Metastatic Breast Cancer MediLink Therapeutics (Suzhou) Co., Ltd. 180
Testing effectiveness (Phase 2)UnknownNCT06000033What this trial is testingStudy of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast CancerWho this might be right forBreast Cancer Qilu Hospital of Shandong University 35
Early research (Phase 1)Study completedNCT04147819What this trial is testingA First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 ProteinWho this might be right forCancers With HER2 Expression Bayer 14
Not applicableNot Yet RecruitingNCT07035353What this trial is testingA Real-world Clinical Study of T-DXd for the Treatment of Chinese Patients With HER2 Overexpressing and HER2 Underexpressing Advanced Breast CancerWho this might be right forHER2 OverexpressionAdvanced Stage Breast CancerLow Expression of HER2 Tianjin Medical University Cancer Institute and Hospital 200
Testing effectiveness (Phase 2)UnknownNCT05953168What this trial is testingT-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low PatientsWho this might be right forTriple-Negative Breast Cancer Fudan University 69